(VIANEWS) – Opera Limited (OPRA), Farmers National Banc Corp. (FMNB), IDEXX Laboratories (IDXX) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Opera Limited (OPRA)
21.2% sales growth and 4.35% return on equity
Opera Limited, together with its subsidiaries, provides mobile and PC web browsers. The company offers mobile browser products, such as Opera Mini, Opera for Android, and Opera Touch; PC browsers, including Opera for Computers and Opera GX; Opera News, a personalized news aggregation app; and Okash, a microfinance app. It operates in India, Ireland, Kenya, Russia, and internationally. The company was founded in 1996 and is headquartered in Oslo, Norway. As of January 13, 2021, Opera Limited (NasdaqGS : OPRA) operates as subsidiary of Kunlun Tech Limited.
Earnings Per Share
As for profitability, Opera Limited has a trailing twelve months EPS of $0.4.
PE Ratio
Opera Limited has a trailing twelve months price to earnings ratio of 45.62. Meaning, the purchaser of the share is investing $45.62 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.35%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Opera Limited’s EBITDA is 35.68.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Jun 28, 2023, the estimated forward annual dividend rate is 0.8 and the estimated forward annual dividend yield is 3.85%.
Moving Average
Opera Limited’s value is below its 50-day moving average of $18.56 and way higher than its 200-day moving average of $10.06.
Sales Growth
Opera Limited’s sales growth is 17.8% for the current quarter and 21.2% for the next.
2. Farmers National Banc Corp. (FMNB)
10.5% sales growth and 13.49% return on equity
Farmers National Banc Corp., a financial holding company, operates in the banking, trust, retirement consulting, insurance, and financial management industries. It offers commercial and retail banking services, including checking, savings, and time deposit accounts; commercial, mortgage and installment, and home equity loans; home equity lines of credit, night depository, safe deposit box, money order, bank check, automated teller machine, Internet banking, travel card, E bond transaction, MasterCard and Visa credit cards, brokerage, and other services. The company also provides personal and corporate trust services in the areas of estate settlement, trust administration, and employee benefit plans; retirement services; property and casualty insurance products and services; and various insurance products through licensed representatives, as well as invests in municipal securities. It operates through 47 locations in northeastern region of Ohio and one location in southwestern Pennsylvania. The company was founded in 1887 and is based in Canfield, Ohio.
Earnings Per Share
As for profitability, Farmers National Banc Corp. has a trailing twelve months EPS of $1.51.
PE Ratio
Farmers National Banc Corp. has a trailing twelve months price to earnings ratio of 8.52. Meaning, the purchaser of the share is investing $8.52 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.49%.
Sales Growth
Farmers National Banc Corp.’s sales growth is 13% for the present quarter and 10.5% for the next.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is a negative 16.3% and a negative 16.7%, respectively.
Volume
Today’s last reported volume for Farmers National Banc Corp. is 58459 which is 47.12% below its average volume of 110559.
3. IDEXX Laboratories (IDXX)
9.9% sales growth and 94.43% return on equity
IDEXX Laboratories, Inc. develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It also provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory animal diagnostic instruments, and services for biomedical research community. In addition, the company offers diagnostic and health-monitoring products for livestock, poultry, and dairy products that test water for various microbiological contaminants; point-of-care electrolytes and blood gas analyzers; OPTI SARS-CoV-2 RT-PCR test kit for human COVID-19 testing; in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, and coagulation analyzers; and SNAP rapid assays test kits. Further, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; and veterinary software and services for independent veterinary clinics and corporate groups. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.
Earnings Per Share
As for profitability, IDEXX Laboratories has a trailing twelve months EPS of $8.29.
PE Ratio
IDEXX Laboratories has a trailing twelve months price to earnings ratio of 61.4. Meaning, the purchaser of the share is investing $61.4 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 94.43%.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 58.3% and 11.6%, respectively.
Revenue Growth
Year-on-year quarterly revenue growth grew by 7.6%, now sitting on 3.43B for the twelve trailing months.
Earnings Before Interest, Taxes, Depreciation, and Amortization
IDEXX Laboratories’s EBITDA is 152.87.
4. JP Morgan Chase (JPM)
8.4% sales growth and 15.98% return on equity
JPMorgan Chase & Co. operates as a financial services company worldwide. It operates through four segments: Consumer & Community Banking (CCB), Corporate & Investment Bank (CIB), Commercial Banking (CB), and Asset & Wealth Management (AWM). The CCB segment offers deposit, investment and lending products, cash management, and payments and services to consumers and small businesses; mortgage origination and servicing activities; residential mortgages and home equity loans; and credit cards, auto loans, leases, and travel services. The CIB segment provides investment banking products and services, including corporate strategy and structure advisory, and equity and debt markets capital-raising services, as well as loan origination and syndication; payments and cross-border financing; and cash and derivative instruments, risk management solutions, prime brokerage, and research. This segment also offers securities services, including custody, fund accounting and administration, and securities lending products for asset managers, insurance companies, and public and private investment funds. The CB segment provides financial solutions, including lending, payments, investment banking, and asset management to small and midsized companies, local governments, nonprofit clients, and large corporations; and commercial real estate banking services to investors, developers, and owners of multifamily, office, retail, industrial, and affordable housing properties. The AWM segment offers multi-asset investment management solutions in equities, fixed income, alternatives, and money market funds to institutional clients and retail investors; and retirement products and services, brokerage, custody, estate planning, lending, deposits, and investment management products. The company also provides ATM, online and mobile, and telephone banking services. JPMorgan Chase & Co. was founded in 1799 and is headquartered in New York, New York.
Earnings Per Share
As for profitability, JP Morgan Chase has a trailing twelve months EPS of $15.56.
PE Ratio
JP Morgan Chase has a trailing twelve months price to earnings ratio of 10.04. Meaning, the purchaser of the share is investing $10.04 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.98%.
Sales Growth
JP Morgan Chase’s sales growth is 23.2% for the current quarter and 8.4% for the next.
Volume
Today’s last reported volume for JP Morgan Chase is 3259340 which is 68.46% below its average volume of 10335100.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Jul 4, 2023, the estimated forward annual dividend rate is 4 and the estimated forward annual dividend yield is 2.55%.
5. Armada Hoffler Properties (AHH)
7.3% sales growth and 10.69% return on equity
Armada Hoffler Properties, Inc. (NYSE: AHH) is a vertically-integrated, self-managed real estate investment trust ("REIT") with four decades of experience developing, building, acquiring, and managing high-quality, institutional-grade office, retail, and multifamily properties located primarily in the Mid-Atlantic and Southeastern United States. In addition to developing and building properties for its own account, the Company also provides development and general contracting construction services to third-party clients. Founded in 1979 by Daniel A. Hoffler, the Company has elected to be taxed as a REIT for U.S. federal income tax purposes.
Earnings Per Share
As for profitability, Armada Hoffler Properties has a trailing twelve months EPS of $0.86.
PE Ratio
Armada Hoffler Properties has a trailing twelve months price to earnings ratio of 13.88. Meaning, the purchaser of the share is investing $13.88 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.69%.
Sales Growth
Armada Hoffler Properties’s sales growth is 4.3% for the current quarter and 7.3% for the next.
Previous days news about Armada Hoffler Properties(AHH)
- Armada hoffler properties (ahh) reports Q2 earnings: what key metrics have to say. According to Zacks on Thursday, 3 August, "For the quarter ended June 2023, Armada Hoffler Properties (AHH Quick QuoteAHH – Free Report) reported revenue of $59.95 million, up 8.6% over the same period last year. ", "Here is how Armada Hoffler Properties performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:"
6. PayPal (PYPL)
7% sales growth and 13.37% return on equity
PayPal Holdings, Inc. operates a technology platform that enables digital payments on behalf of merchants and consumers worldwide. The company provides payment solutions under the PayPal, PayPal Credit, Braintree, Venmo, Xoom, PayPal Zettle, Hyperwallet, PayPal Honey, and Paidy names. Its payments platform allows consumers to send and receive payments in approximately 200 markets and in approximately 150 currencies, withdraw funds to their bank accounts in 56 currencies, and hold balances in their PayPal accounts in 25 currencies. The company was founded in 1998 and is headquartered in San Jose, California.
Earnings Per Share
As for profitability, PayPal has a trailing twelve months EPS of $2.32.
PE Ratio
PayPal has a trailing twelve months price to earnings ratio of 27.79. Meaning, the purchaser of the share is investing $27.79 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.37%.
Previous days news about PayPal(PYPL)
- According to MarketWatch on Wednesday, 2 August, "That streak of 47 sessions in which the S&P 500 reported , CVS Health , and after the close, MetLife and PayPal . "
- Is PayPal (pypl) A buy ahead of Q2 earnings announcement?. According to Zacks on Tuesday, 1 August, "Digital payments company PayPal (PYPL Quick QuotePYPL – Free Report) is set to report second-quarter earnings results on Wednesday after the bell. ", "Owner of the popular PayPal and Venmo payment services, PayPal is a Zacks Rank #3 (Hold) stock. "
- PayPal’s stock falls as earnings beat, but a margin metric misses. According to MarketWatch on Wednesday, 2 August, "On an adjusted basis, PayPal earned $1.16 a share, up from 93 cents a share a year prior, while the FactSet consensus was for $1.15 a share.", "The payments company reported second-quarter net income of $1.03 billion, or 92 cents a share, whereas PayPal recorded a net loss of $341 million, or 29 cents a share, in the year-earlier period. "
- According to MarketWatch on Wednesday, 2 August, "On Tuesday, the Dow Jones Industrial Average gaining 0.7%, gold nudging up to $1,950 an ounce, and benchmark German government bond yields , Humana and Carlyle Group before the opening bell, followed after the close by PayPal , Shopify and Qualcomm ."
7. Teleflex (TFX)
5.7% sales growth and 9.18% return on equity
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. The company also offers interventional products, which consists of various coronary catheters, structural heart therapies, and peripheral intervention and cardiac assist products that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded catheters, Guideline, Turnpike, and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. It provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. The company also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; and respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings. It provides urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. The company was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.
Earnings Per Share
As for profitability, Teleflex has a trailing twelve months EPS of $7.68.
PE Ratio
Teleflex has a trailing twelve months price to earnings ratio of 31. Meaning, the purchaser of the share is investing $31 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.18%.
Yearly Top and Bottom Value
Teleflex’s stock is valued at $238.09 at 20:22 EST, way under its 52-week high of $276.43 and way higher than its 52-week low of $182.65.
Moving Average
Teleflex’s worth is below its 50-day moving average of $242.77 and below its 200-day moving average of $239.79.
Volume
Today’s last reported volume for Teleflex is 359027 which is 22.71% above its average volume of 292577.
Revenue Growth
Year-on-year quarterly revenue growth grew by 10.8%, now sitting on 2.86B for the twelve trailing months.
Previous days news about Teleflex(TFX)
- Compared to estimates, teleflex (tfx) Q2 earnings: A look at key metrics. According to Zacks on Thursday, 3 August, "For the quarter ended June 2023, Teleflex (TFX Quick QuoteTFX – Free Report) reported revenue of $743.26 million, up 5.5% over the same period last year. ", "Here is how Teleflex performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:"
